DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines

被引:49
作者
Kawamoto, Ken [2 ]
Hirata, Hiroshi [2 ]
Kikuno, Nobuyuki [2 ]
Tanaka, Yuichiro [2 ]
Nakagawa, Masayuki [3 ]
Dahiya, Rajvir [1 ,2 ]
机构
[1] Vet Affairs Med Ctr, Urol Res Ctr 112F, Dept Urol, San Francisco, CA 94121 USA
[2] Univ Calif San Francisco, Sch Med, San Francisco, CA 94121 USA
[3] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Urol, Kagoshima 890, Japan
关键词
sFRP2; gene; Wnt antagonist; DNA methylation; histone modification; renal cell carcinoma;
D O I
10.1002/ijc.23514
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Secreted frizzled-related protein 2 (sFRP2) is a negative modulator of the Wingless-type (Wnt) signaling pathway, and shown to be inactivated in renal cell carcinoma (RCC). However, the molecular mechanism of silencing of sFRP2 is not fully understood. Our study was designed to elucidate the silencing mechanism of sFRP2 in RCC. Expression of sFRP2 was examined in 20 pairs of primary cancers by immunohistochemistry. Kidney cell lines (HK-2, Caki-1, Caki-2, A-498 and ACHN) were analyzed for sFRP2 expression using real-time RT-PCR and Western blotting. The methylation status at 46 CpG sites of the 2 CpG islands in the sFRP2 promoter was characterized by bisulfite DNA sequencing. Histone modifications were assessed by chromatin immunoprecipitation (ChIP) assay using antibodies against AcH3, AcH4, H3K4 and H3K9. sFRP2 was frequently repressed in primary cancers and in RCC cells. The majority of sFRP2 negative cells had a methylated promoter. Meanwhile, sFRP2 expression was repressed by a hypomethylated promoter in Caki-1 cells, and these cells had a repressive histone modification at the promoter. In Caki-1 cells, sFRP2 was reactivated by trichostatin A (TSA). Repressive histone modifications were also observed in RCC cells with hypermethylated promoters, but sFRP2 was reactivated only by 5-aza-2'-deoxycytidine (DAC) and not by TSA. However, the activation of the silenced sFRP2 gene could be achieved in all cells using a combination of DAC and TSA. This is the first report indicating that aberrant DNA methylation and histone modifications work together to silence the sFRP2 gene in RCC cells. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:535 / 542
页数:8
相关论文
共 46 条
  • [21] Secreted antagonists of the Wnt signalling pathway
    Kawano, Y
    Kypta, R
    [J]. JOURNAL OF CELL SCIENCE, 2003, 116 (13) : 2627 - 2634
  • [22] Blockade of paclitaxel-induced thymidine phosphorylase expression can accelerate apoptosis in human prostate cancer cells
    Kikuno, N
    Moriyama-Gonda, N
    Yoshino, T
    Yoneda, T
    Urakami, S
    Terashima, M
    Yoshida, M
    Kishi, H
    Shigeno, K
    Shiina, H
    Igawa, M
    [J]. CANCER RESEARCH, 2004, 64 (20) : 7526 - 7532
  • [23] Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer
    Kondo, Y
    Shen, LL
    Issa, JPJ
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (01) : 206 - 215
  • [24] MethPrimer: designing primers for methylation PCRs
    Li, LC
    Dahiya, R
    [J]. BIOINFORMATICS, 2002, 18 (11) : 1427 - 1431
  • [25] Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway
    McCabe, MT
    Davis, JN
    Day, ML
    [J]. CANCER RESEARCH, 2005, 65 (09) : 3624 - 3632
  • [26] Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state
    McGarvey, KM
    Fahrner, JA
    Greene, E
    Martens, J
    Jenuwein, T
    Baylin, SB
    [J]. CANCER RESEARCH, 2006, 66 (07) : 3541 - 3549
  • [27] SARPs: A family of secreted apoptosis-related proteins
    Melkonyan, HS
    Chang, WC
    Shapiro, JP
    Mahadevappa, M
    Fitzpatrick, PA
    Kiefer, MC
    Tomei, LD
    Umansky, SR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (25) : 13636 - 13641
  • [28] Silencing effect of CpG island hypermethylation and histone modifications on O6-methylguanine-DNA methyltransferase (MGMT) gene expression in human cancer
    Nakagawachi, T
    Soejima, H
    Urano, T
    Zhao, W
    Higashimoto, K
    Satoh, Y
    Matsukura, S
    Kudo, S
    Kitajima, Y
    Harada, H
    Furukawa, K
    Matsuzaki, H
    Emi, M
    Nakabeppu, Y
    Miyazaki, K
    Sekiguchi, M
    Mukai, T
    [J]. ONCOGENE, 2003, 22 (55) : 8835 - 8844
  • [29] The role of epigenetic modifications in retinoic acid receptor β2 gene expression in human prostate cancers
    Nakayama, T
    Watanabe, M
    Yamanaka, M
    Hirokawa, Y
    Suzuki, H
    Ito, H
    Yatani, R
    Shiraishi, T
    [J]. LABORATORY INVESTIGATION, 2001, 81 (07) : 1049 - 1057
  • [30] MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex
    Ng, HH
    Zhang, Y
    Hendrich, B
    Johnson, CA
    Turner, BM
    Erdjument-Bromage, H
    Tempst, P
    Reinberg, D
    Bird, A
    [J]. NATURE GENETICS, 1999, 23 (01) : 58 - 61